NCT01628757 Model Development and Prospective Validation to Predict the Response to Neoadjuvant Chemotherapy in Cervical Cancer Status UNKNOWN Phase N/A
NCT01613521 Tumor Perfusion and Hypoxia Assessed by DCE-MRI and 18F-FMISO PET as Biomarkers of Treatment Response in Cervical Cancer Status TERMINATED Phase NA
NCT01613430 Evaluating Coaches of Older Adults for Cancer Care and Health Behaviors Status COMPLETED Phase NA
NCT01606293 Use of Social Networking to Survey Women With Small and Large Cell Carcinomas of the Cervix Status UNKNOWN Phase N/A
NCT01600040 Proton Beam Teletherapy for Post-Hysterectomy Cancers of the Uterus and Cervix Status COMPLETED Phase NA
NCT01594099 Concurrent Chemoradiotherapy for Cervical Cancer in Elderly Women Status UNKNOWN Phase PHASE2
NCT01590017 Cisplatin and Radiation Therapy in Treating Patients With HIV-Associated Locally Advanced Cervical Cancer Status COMPLETED Phase PHASE2
NCT01588301 Self-sampling and Human Papillomavirus (HPV)-Testing for Unscreened Women in Cervical Cancer Prevention Status COMPLETED Phase EARLY_PHASE1
NCT01585428 Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Human Papillomavirus-Associated Cancers Status COMPLETED Phase PHASE2
NCT01584414 Evaluation of the Zetiq Histological and Cytological Staining Technique for the Detection Cervical Cancer Status COMPLETED Phase N/A
NCT01583686 CAR T Cell Receptor Immunotherapy Targeting Mesothelin for Patients With Metastatic Cancer Status TERMINATED Phase PHASE1/PHASE2
NCT01566240 Induction Chemotherapy Plus Chemoradiation as First Line Treatment for Locally Advanced Cervical Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT01561586 Tri-weekly Cisplatin Based Chemoradiation in Locally Advanced Cervical Cancer Status UNKNOWN Phase PHASE3
NCT01554397 Study With Intensity Modulated Radiation Therapy With Cisplatin to Treat Stage I-IVA Cervical Cancer Status COMPLETED Phase PHASE2/PHASE3
NCT01546363 Tissue and Plasma Biomarkers of Lymph Node Involvement in Cervical Cancer Status COMPLETED Phase N/A
NCT01544478 V501 Safety and Efficacy Study in Japanese Women Aged 16 to 26 Years (V501-110) Status COMPLETED Phase PHASE4